Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study

BACKGROUND/AIMS: Recently neoadjuvant chemotherapy (NAC) for pancreatic cancer has been shown to be superior to upfront surgery, but it remains a matter of debate for resectable cases. In clinical practice, some resectable cases may become unresectable after NAC. This study aimed to reveal the outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Murakami, Masatoshi, Fujimori, Nao, Ohno, Akihisa, Matsumoto, Kazuhide, Teramatsu, Katsuhito, Takamatsu, Yu, Takeno, Ayumu, Oono, Takamasa, Abe, Toshiya, Ideno, Noboru, Ikenaga, Naoki, Nakata, Kohei, Nakamura, Masafumi, Ishigami, Kousei, Ogawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777497/
https://www.ncbi.nlm.nih.gov/pubmed/35201490
http://dx.doi.org/10.1007/s12672-021-00462-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777497/
https://www.ncbi.nlm.nih.gov/pubmed/35201490
http://dx.doi.org/10.1007/s12672-021-00462-1

Ejemplares similares